# Parkervision Inc: Form 10-Q for the period ended Mar 31, 2020

- Company: [Parkervision Inc](/companies/prkr.md) (CIK 914139)
- Form: 10-Q
- Filed: 2020-05-15
- Accepted by EDGAR: May 15, 2020, 16:06 ET
- Period: 2020-03-31
- Accession: 0000914139-20-000045
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914139/000091413920000045/prkr-20200331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914139/000091413920000045/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $5.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $186.0k | us-gaap:InterestExpense |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$7.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.21 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | −$1.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2020-03-31 | $173.0k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $912.0k | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $4.0m | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $6.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $40.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2020-03-31 | −$36.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,239 characters.

#### Forward-Looking Statements

We believe that it is important to communicate our future expectations to our shareholders and to the public. This quarterly report contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, including, in particular, statements about our future plans, objectives, and expectations contained in this Item. When used in this quarterly report and in future filings by us with the Securities and Exchange Commission (“SEC”), the words or phrases “expects”, “will likely result”, “will continue”, “is anticipated”, “estimated” or similar expressions are intended to identify “forward-looking statements.” Readers are cautioned not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results and those presently anticipated or projected, including the risks and uncertainties identified in our annual report on Form 10-K for the fiscal year ended December 31, 2019 (the “2019 Annual Report”) and in this Item 2 of Part I of this quarterly report. Examples of such risks and uncertainties include general economic and business conditions, competition, unexpected changes in technologies and technological advances, the timely development and commercial acceptance of new products and technologies, reliance on key suppliers, reliance on our intellectual property, the outcome of our intellectual property litigation and the ability to obtain adequate financing in the future. We have no obligation to publicly release the results of any revisions which may be made to any forward-looking statements to reflect anticipated events or circumstances occurring after the date of such statements.

#### Corporate Website

We announce investor information, including news and commentary about our business, financial performance and related matters, SEC filings, notices of investor events, and our press and earnings releases, in the investor relations section of our website (http://ir.parkervision.com). Additionally, if applicable, we webcast our earnings calls and certain events we participate in or host with members of the investment community in the investor relations section of our website. Investors and others can receive notifications of new information posted in the investor relations section in real time by signing up for email alerts and/or RSS feeds. Further corporate governance information, including our governance guidelines, Board committee charters, and code of conduct, is also available in the investor relations section of our website under the heading “Corporate Governance.” The content of our website is not incorporated by reference into this Annual Report or in any other report or document we file with the SEC, and any references to our website are intended to be inactive textual references only.

#### Overview

We have designed and developed proprietary radio frequency (“RF”) technologies and integrated circuits for use in wireless communication products. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent infringement litigation and licensing efforts. We currently have patent enforcement actions ongoing in various U.S. district courts against mobile handset providers and their chip suppliers for the infringement of a number of our RF patents. We have made significant investments in developing and protecting our technologies, the returns on which are dependent upon the generation of future revenues for realization.

#### Recent Developments

#### Impact of COVID-19

Many states, including Florida, have been under a stay-at-home order since mid-March 2020 in an effort to contain the spread of COVID-19. While our employees currently have the ability and are encouraged to work remotely, school closures and other stay-at-home measures have an impact on employee productivity and attendance. In addition, we have experienced delays in certain deadlines in our patent infringement litigation as a result of court closures, travel bans and stay-at-home measures in Florida as well as other states in which we have ongoing litigation and states in which the defendants to our patent infringement actions have personnel and facilities. In addition, the current economic environment as a result of COVID-19 makes access to debt and equity capital more challenging.

In May 2020, we received approximately $0.2 million in proceeds from an approved loan under the Paychecks Protection Program. Interest will accrue on outstanding principal balance at a rate of 1%, computed on a simple interest basis. The loan principal and accrued interest will be eligible for forgiveness provided that (i) we use the loan proceeds exclusively for allowed costs including payroll, employee group health benefits, rent and utilities and (ii) employee and compensation levels are maintained. If the loan is not forgiven, we will be required to make monthly repayments of approximately $8,000 per month commencing November 1, 2020 and the loan will mature on May 3, 2022, at which time any unpaid principal and accrued interest will be due and payable.

#### Legal Proceedings

In April 2020, the district court in the Middle District of Florida (Orlando division) issued its claim construction order in *Parkervision v. Qualcomm and HTC* whereby the court adopted the majority of our proposed claim construction language for the disputed terms. This court currently has a stay in place for all scheduled discovery and deadlines in response to COVID-19. The stay is expected to last at least through May 29, 2020.

In addition, the district court in the Middle District of Florida (Jacksonville division) ruled to stay the *ParkerVision v. Qualcomm and Apple* action, in response to a joint motion filed by us and Apple requesting a stay of this action pending the resolution of the case in the Orlando division against Qualcomm and HTC. This case had originally been scheduled for trial commencing in August 2020 but was under an administrative stay due to the impact of COVID-19.

In May 2020, we amended our complaint in *ParkerVision v. Intel* in Texas to add two patents to the case that was originally filed in February 2020. We also filed an action against Chinese TCL Technology Group Corp and its U.S. subsidiary TTE Technology, Inc. (collectively “TCL”) in U.S. district court in the Central District of California alleging infringement of nine of our patents. TCL products included in the action incorporate modules that contain certain Wi-Fi chips manufactured by Realtek Semiconductor Corporation, a Taiwanese IC provider. The law firm of Goldberg Segalla is representing us on a contingency fee basis in both the Intel and TCL cases.

#### Equity Financing

In April 2020, we received aggregate net proceeds of $0.5 million from the sale of equity securities with contingent payment rights. The contingent payment rights entitle the investors to an allocated portion of our share of proceeds from patent-related actions, after taking into account fees and expenses payable to law firms representing us and amounts payable to Brickell, up to an aggregate of $0.5 million. Additionally, on May 1, 2020, we entered into an amendment to certain March 2020 securities purchase agreements to add a contingent payment right for the investors, up to an aggregate of $0.9 million.

#### Liquidity and Capital Resources

We have incurred significant losses from operations and negative operating cash flows in every year since inception, largely as a result of our significant investments in developing and protecting our intellectual property, and have utilized the proceeds from the sales of our equity securities and contingent funding arrangements with third-parties to fund our operations, including the cost of litigation.

We used cash for operations of approximately $1.3 million and $1.7 million for the three months ended March 31, 2020 and 2019, respectively. At March 31, 2020, we had cash and cash equivalents of $0.2 million, a working capital deficit of approximately $5.4 million, and an accumulated deficit of approximately $409.7 million. These circumstances raise substantial doubt about our ability to continue to operate as a going concern within one year following the issue date of our condensed consolidated financial statements.

For the three months ended March 31, 2020, we received aggregate net proceeds from the sale of debt and equity securities of approximately $1.5 million, proceeds from the exercise of outstanding warrants of approximately $0.5 million and advances from a potential litigation funding party of approximately $0.6 million. In addition, we repaid approximately $0.7 million in short-term debt and other accrued expenses through the use of shares of our common stock. Despite these funding efforts, our resources are not sufficient to meet our short-term liquidity needs and we will be required to seek additional capital.

In addition, we are exploring additional financing opportunities for both our short and long-term capital needs. These financing opportunities may include debt, convertible debt, common or preferred equity offerings, or a combination thereof. There can be no assurance that we will be able to consummate a financing transaction or that the terms of such financing will be on terms and conditions that are acceptable.

Our ability to meet our short-term liquidity needs, including our debt repayment obligations, is dependent upon (i) our ability to successfully negotiate licensing agreements and/or settlements relating to the use of our technologies by others in excess of our contingent payment obligations to Brickell, legal counsel, and other investors; and (ii) our ability to raise additional capital from the sale of equity securities or other financing arrangements.

Patent enforcement litigation is costly and time-consuming and the outcome is difficult to predict. We expect to continue to invest in the support of our patent enforcement and licensing programs. We expect that revenue generated from patent enforcement actions and/or technology licenses in 2020, if any, after deduction of payment obligations to Brickell, legal counsel, and other investors, may not be sufficient to cover our operating expenses. In the event we do not generate revenues, or other patent-related proceeds, sufficient to cover our operational costs and contingent repayment obligation, we will be required to raise additional working capital through the sale of equity securities or other financing arrangements.

The long-term continuation of our business plan is dependent upon the generation of sufficient revenues from our technologies and/or products to offset expenses and contingent payment obligations. In the event that we do not generate sufficient revenues, we will be required to obtain additional funding through public or private debt or equity financing or contingent fee arrangements and/or reduce operating costs. Failure to generate sufficient revenues, raise additional capital through debt or equity financings or contingent fee arrangements, and/or reduce operating costs will have a material adverse effect on our ability to meet our long-term liquidity needs and achieve our intended long-term business objectives.

#### Results of Operations for Each of the Three Months Ended March 31, 2020 and 2019

### Revenue and Gross Margin

We reported no licensing revenue for the three-month periods ended March 31, 2020 or 2019. Although we do anticipate licensing revenue and/or settlement gains to result from our licensing and patent enforcement actions, the amount and timing is highly unpredictable and there can be no assurance that we will achieve our anticipated results.

Due to our ceasing the sales of Milo products in the fourth quarter of 2019, we reported no product revenue for the three-month period ended March 31, 2020. We reported approximately $0.01 million for the three-month period ended March 31, 2019, from sales of our Milo-branded WiFi products.

### Research and Development Expenses

Subsequent to March 31, 2019, we halted substantially all research and development efforts and, where applicable, repurposed prior engineering resources to support our patent enforcement programs or our Milo sales and support. Research and development expenses for the three-month period ended March 31, 2019 consist primarily of engineering and related management and support personnel costs; software licensing and support costs, which represent the annual licensing and support maintenance for engineering design and other software tools; and an allocated portion of rent and other overhead costs for our facilities. Personnel costs include share-based compensation which represents the grant date fair value of equity-based awards to our employees which is attributed to expense over the service period of the award.

Our research and development expenses decreased by approximately $0.3 million, or 100.0%, during the three months ended March 31, 2020 when compared to the same three-month period in 2019. The decrease is primarily the result of a $0.1 million reduction in personnel costs. Additionally, research and development expenses decreased by approximately $0.2 million due to personnel and related costs being repurposed for selling, general and administrative purposes, including litigation support and Milo sales and support.

### Selling, General, and Administrative Expenses

Selling, general and administrative expenses consist primarily of litigation fees and expenses, executive, board, sales and marketing, and finance and administrative personnel costs, including share-based compensation, and costs incurred for advertising, insurance, outside accounting and legal professional fees, shareholder relations and noncash expenses including amortization and compensation expense in connection with equity offerings.

Our selling, general and administrative expenses increased by approximately $3.3 million, or 155%, during the three months ended March 31, 2020 when compared to the same period in 2019. This is primarily the result of a $1.6 million increase in litigation fees and expenses, the recognition of warrant expense of approximately $1.8 million, and an increase in share-based compensation of $0.3 million, somewhat offset by a decrease in Board compensation of $0.3 million.

Litigation-related fees and expenses were $2.7 million during the three months ended March 31, 2020, compared with $1.1 million during the three months ended March 31, 2019. The increase in litigation related fees and expenses for the three months ended March 31, 2020 is primarily the result of increased activity during the first quarter of 2020 for the Middle District of Florida (Jacksonville division) case in *ParkerVision v. Apple and Qualcomm* for depositions and expert reports. Litigation-related fees and expenses incurred during the first quarter of 2019 primarily related to our litigation in Germany which concluded in 2019.

We incurred a noncash charge to warrant expense during the three months ended March 31, 2020 in connection with a warrant amendment agreement with Aspire Capital whereby we repriced 5,000,000 existing warrants from $0.74 to $0.35 and issued 5,000,000 replacement warrants at $0.74. The expense represents the increase in the estimated fair value, using the Black-Scholes method, of the Aspire warrants immediately before and after the amendment.

The increase in share-based compensation is due to executive and Board equity awards in August 2019 and January and February 2020. This increase is offset by a decrease in Board compensation expense due to the settlement of previously accrued Board fees in exchange for equity-based awards during the first quarter of 2020.

### Change in Fair Value of Contingent Payment Obligations

We have elected to measure our secured and unsecured contingent payment obligations at fair value which is based on significant unobservable inputs. We estimated the fair value of our secured contingent payment obligations using an income approach based on the estimated present value of projected future cash outflows using a risk-adjusted discount rate. Increases or decreases in the significant unobservable inputs could result in significant increases or decreases in fair value.

For the three months ended March 31, 2020, we recorded an increase in the fair value of our secured contingent payment obligation of approximately $0.8 million, compared to a decrease of approximately $0.5 million for same period in 2019. Generally, changes in fair value are a result of changes in estimated amounts and timing of projected future cash flows due to increases in funded amounts, passage of time, and changes in the probabilities based on the status of the funded actions. The change in fair value of our secured contingent payment obligation during the three months ended March 31, 2020 is primarily due to a sharp decrease in the risk free interest rate used to discount projected future cash outflows.

For the three months ended March 31, 2020, we also recorded a $1.4 million increase in the fair value of an unsecured contingent payment obligation. This contingent payment obligation is the result of a failed financing arrangement whereby we received $1.0 million in advance payments against a contingent funding arrangement. Upon the failure to consummate that funding agreement by March 31, 2020, we are obligated to repay up to $5.0 million as a termination fee, from future patent-related proceeds. As this repayment obligation is dependent upon our receipt of future proceeds, we elected to account for this obligation at its estimated fair value. The increase in fair value of $1.4 million reflects the initial fair value measure of this liability based on projected future cash flows and probabilities based on the status of our patent infringement actions.

#### Off-Balance Sheet Transactions, Arrangements and Other Relationships

As of March 31, 2020 we had outstanding warrants to purchase approximately 15.9 million shares of our common stock. The estimated grant date fair value of these warrants of approximately $2.7 million is included in shareholders’ deficit in our condensed consolidated balance sheets. The outstanding warrants have a weighted average exercise price of $0.43 per share and a weighted average remaining life of approximately 3.4 years.

#### Critical Accounting Policies

There have been no changes in accounting policies from those stated in our 2019 Annual Report. We do not expect any newly effective accounting standards to have a material impact on our financial position, results of operations or cash flows when they become effective.

## Market risk

As filed, 1,196 characters.

We have a note in the principal amount of $0.02 million payable to Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (“Mintz”) for outstanding, unpaid attorney’s fees and costs associated with our patent enforcement program. We have been in payment default on the note since November 17, 2019, and accordingly, have accrued interest at the default rate of 12% per annum. Currently, Mintz has not requested acceleration of unpaid principal and interest on the note, nor have they waived the outstanding default. During the three months ended March 31, 2020, we made payments to Mintz of $1.2 million which we applied to outstanding principal and interest on the Mintz note, leaving an outstanding balance at March 31, 2020 of approximately $0.02 million. Mintz disputes our application of payments against principal and interest on the note rather than against the $2.9 million in outstanding billed and unpaid fees and expenses payable to Mintz that are included in our accounts payable at March 31, 2020. We are in active discussions with Mintz to resolve our outstanding fee dispute. Our total arrearage on the secured note as of May 15, 2020 is $0.02 million which includes default interest.

## Controls and procedures

As filed, 945 characters.

#### Evaluation of Disclosure Controls and Procedures

As of March 31, 2020, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our “disclosure controls and procedures,” as defined in Rule 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures were effective as of March 31, 2020.

#### Changes in Internal Control Over Financial Reporting

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 395 characters.

There have been no material changes from the risk factors disclosed in Item 1A of Part I of our Annual Report. In addition to the information in this quarterly report, the risk factors disclosed in our Annual Report should be carefully considered in evaluating our business because such factors may have a significant impact on our business, operating results, liquidity and financial condition.

Filed May 15, 2020.
Source: SEC EDGAR, the filing index for accession 0000914139-20-000045. Last ingested by Listed: Nov 11, 2026, 01:56 ET. No prices; not investment advice.
